
    
      Oral administration of an oligomeric formula with milk proteins, mainly whey protein
      partially hydrolysate, monounsaturated fatty acids (AGM) and low dextrose equivalent
      maltodextrin and enriched in polyunsaturated fatty acids (PUFA) of omega-3 series, EPA and
      DHA, and MCT designed for nutritional support of patients with compromised intestinal
      function, to maintain or improve nutritional status and reduce the inflammatory response in
      undernourished patients with mild acute pancreatitis, compared with oligomeric enteral
      nutrition product, low in fat and rich in glutamine.
    
  